MBK-01 for recurrent diverticulitis
Part of Digestive system clinical trials.
This trial tests MBK-01, capsules made from healthy gut bacteria, to see if they can help people who keep getting diverticulitis. If you've had three or more bouts in the last three years, this study might offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You've had at least three episodes of diverticulitis in the last 3 years, confirmed by a CT scan or ultrasound.
- Your last diverticulitis episode was more than 30 days ago.
- You have not had colon surgery or any colon removed.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You can follow contraceptive rules if you're of reproductive age.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how treatment affects quality of life in people with left-sided diverticulitis, including repeat episodes or complicated attacks. It may help doctors understand what improves day-to-day well-being and recovery for different diverticulitis situations.
This study looks at how the bacteria in your gut might be related to diverticular disease (pouches in your colon). If you have had diverticulitis, researchers want to see if your gut microbiome is different from people without the condition.
This study tests whether some patients with mild diverticulitis (inflammation in the colon) can recover without antibiotics, using rest and supportive care instead. If it works, it could help avoid unnecessary antibiotics and their side effects.
This trial tests if mild diverticulitis (a small infection in the colon) can be safely treated at home without antibiotics. If you have this condition and are otherwise healthy, you may be able to avoid a hospital stay.
This study tests a tool to help doctors decide whether to reconnect the colon or create a temporary opening (colostomy) during emergency surgery for severe diverticulitis. The goal is to improve patient outcomes by supporting better surgical decisions.
This study tests the SIMBA capsule to learn how gut bacteria (dysbiosis) relate to digestive conditions. It may help researchers better understand these conditions and how the capsule can be used safely.
Hear when a new Diverticulitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.